Cardiac Safety Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

ECG/Holter Monitors is the fastest growing sector, North America is the largest market

The Global Cardiac Safety Services Market is projected to grow from USD 883.13 Million in 2025 to USD 1.42 billion by 2031, at an 8.32% CAGR. These services involve specialized monitoring, collection, and analysis of cardiovascular data, such as ECGs and blood pressure readings, performed by vendors during clinical trials to identify potential adverse drug reactions. The market is primarily driven by stringent regulatory mandates from health authorities like the FDA and EMA for rigorous cardiovascular risk assessments in new therapeutics, alongside the increasing global burden of heart-related ailments; the World Heart Federation reported nearly 18 million annual cardiovascular-related deaths in 2025, emphasizing the urgent need for robust safety monitoring in drug development.

Market Drivers

A primary catalyst for the cardiac safety services market is the accelerated outsourcing of clinical trial operations to specialized Contract Research Organizations (CROs). As clinical studies grow in complexity and geographical spread, biopharmaceutical sponsors, especially small to mid-sized entities, increasingly rely on CROs for managing intricate cardiovascular monitoring across diverse regulatory jurisdictions, particularly since emerging biopharma companies initiated 63% of all clinical trials in 2024. Simultaneously, substantial R&D investments in biopharmaceutical development, reaching a ten-year high of $102 billion in 2024, are expanding the pipeline of novel therapeutics like gene therapies and biologics. These new modalities often present unknown cardiac risk profiles, necessitating continuous, high-fidelity monitoring and thereby amplifying the demand for comprehensive cardiac safety testing throughout the drug development lifecycle.

Market Challenges

The Global Cardiac Safety Services Market faces a significant barrier due to the prohibitive costs and logistical complexities of implementing centralized safety monitoring across multinational trial sites. Expanding clinical studies into diverse regulatory jurisdictions imposes a substantial financial burden for standardizing data collection and deploying specialized equipment, proving particularly challenging for small and mid-sized biopharmaceutical organizations lacking the capital for intricate global compliance. These operational hurdles frequently extend study timelines and reduce budget allocation for detailed safety data, hindering the widespread adoption of comprehensive cardiac monitoring services; in 2025, 35% of clinical research sites identified increasing trial complexity as their leading operational challenge, underscoring the difficulties in executing robust safety protocols amidst varying local requirements.

Market Trends

Two pivotal trends are reshaping cardiac safety protocols: the proliferation of medical-grade wearable continuous monitoring devices and the integration of AI-driven ECG interpretation. Wearable biosensors enable high-fidelity, real-world data collection beyond traditional clinical sites, offering longitudinal insights into arrhythmogenic risks that episodic ECGs often miss, exemplified by iRhythm Technologies serving over 2 million patients with its Zio platform in 2024. Concurrently, AI-driven ECG interpretation is becoming essential for managing the vast datasets from continuous monitoring. Advanced machine learning algorithms automate the analysis of cardiovascular safety endpoints, significantly enhancing diagnostic precision and reducing the manual burden on central review teams. For instance, PMcardio's AI algorithm achieved 92% accuracy in identifying acute cardiac events, performing significantly better than standard methods and drastically reducing false alarms.

Key Market Players

• Medpace, Inc.
• IQVIA Holdings Inc.
• Thermo Fisher Scientific Inc.
• Charles River Laboratories International, Inc.
• WuXi AppTec Co., Ltd.
• Nova Research Laboratories LLC
• Laboratory Corporation of America Holdings
• Koninklije Philips N.V.
• ICON Plc
• Richmond Pharmacology Limited

Report Scope

In this report, the Global Cardiac Safety Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac Safety Services Market, by Service:

• ECG/Holter Monitors
• Blood Pressure Monitors
• Cardiovascular Imaging
• Others

Cardiac Safety Services Market, by Type:

• Integrated
• Standalone

Cardiac Safety Services Market, by End Use:

• Pharma & Biopharma Companies
• CROs
• Others

Cardiac Safety Services Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac Safety Services Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.